Pharmacovigilance: A Practical Approach

Author
Edited by Thao Doan, MD, Cheryl Renz, Fabio Lievano, MD, Mondira Bhattacharya, MD and Linda Scarazzini, MD
ISBN
9780323581165
Publication Date
15-08-2018
Learn More
Paperback
$99.99 $89.99
+ WishList
  • Covers the evolving regulatory landscape, as well as current and future use of digital technologies.
  • Uses case studies to ensure content is relevant to everyday practice.
  • Discusses behavioral science and patient perspectives, risk communication, and new frontiers in pharmacovigilance.
  • Consolidates today's available information on this timely topic into one convenient resource.

Written by experts in the field of pharmacovigilance and patient safety, this concise resource provides a succinct, easy-to-digest overview of an increasingly critical area of medical safety. Drs. Thao Doan, Cheryl Renz, Fabio Lievano, Mondira Bhattacharya, and Linda Scarazzini provide essential information for health care professionals, clinical researchers, and regulators who need a comprehensive, up-to-date source of information on the principles and practice of pharmacovigilance.


Key Features
  • Covers the evolving regulatory landscape, as well as current and future use of digital technologies.
  • Uses case studies to ensure content is relevant to everyday practice.
  • Discusses behavioral science and patient perspectives, risk communication, and new frontiers in pharmacovigilance.
  • Consolidates today's available information on this timely topic into one convenient resource.
ADDITIONAL INFORMATION
ISBN 9780323581165
Author Informaiton Edited by Thao Doan, MD, Sr. Medical Director, Medical Safety Evaluation, AbbVie Inc., Chicago. IL; Cheryl Renz, Senior Medical Director, Safety Science, Pharmacovigilance and Patient Safety, AbbVie, North Chicago, Illinois, United States; Fabio Lievano, MD, Vice President, Safety Sciences, Medical Safety Evaluation Pharmacovigilance and Patient Safety AbbVie Inc., Chicago. IL; Mondira Bhattacharya, MD, Head, Benefit-Risk Management, Innovative Platforms Initiative & Epidemiology, Pharmacovigilance and Patient Safety, AbbVie Inc., Chicago. IL and Linda Scarazzini, MD , Vice President, Pharmacovigilance and Patient Safety, AbbVie Inc., Chicago. IL
Table of Content

Introduction

Section I. The Regulatory Enviroment

1. Does Regulation Drive Science or Does Science Drive Regulation?

Section II. Data and Real World Evidence

2. Role of Epidemiology in Pharmaceutical Industry

3. Real World Epidemiologic Studies and Patient Registries

Section III. Benefit-Risk in the Drug Development Life Cycle

4. Signal Management and Methods of Signal Detection

5. Causality Assessment and Examples of Adverse Drug Reactions (Drug Induced Liver Injury, Skin, Major Adverse Cardiac Events and Renal)

6. Product Safety Monitoring in Clinical Trials

7. Benefit-Risk Assessments

8. Communicating benefit risk

9. Pharmacovigilance and Medical Devices

10. Vaccine Safety Surveillance

11. Pharmacovigilance in Special Populations (Pediatrics and Elderly)

12. Pharmacovigilance in Pregnancy

Section IV. The Role of the Digital Revolution

13. Impact and Implications of Technology on Pharmacovigilance

Section V. The Next Frontier

14. The Future of Pharmacovigilance

Publication Date 15-08-2018
Pages 214
Trim 235 x 191 (7 1/2 x 9 1/4)
Stock Status In Stock
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account

Back to top